A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least through ... would decelerate from 4.8% last year, to 4.6% in 2025 and 4.5% in 2026.

Merck's Gardasil vaccine sales over the quarters Still ... compared with analyst forecasts of around $7.4 billion. Total revenue rose to $15.6 billion from $14.6 billion, and came in slightly ...